CENCORA, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
CENCORA, INC. (COR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of 0.00% for the 12-month period ending 2018-09-30, per its 10-K filed 2018-11-20.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2018-11-20
- CENCORA, INC. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2018 was 0.00%.
- CENCORA, INC. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2017 was 0.00%.
- CENCORA, INC. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2016 was -32.80%, a 129.90% decline from fiscal 2015.
- CENCORA, INC. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2015 was 109.70%, a 496.20% increase from fiscal 2014.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month as first filed |
|---|---|---|
| 2018-09-30 | 0.00% 10-K · filed 2018-11-20 | |
| 2017-09-30 | 0.00% 10-K · filed 2018-11-20 | |
| 2016-09-30 | -32.80% 10-K · filed 2018-11-20 | |
| 2015-09-30 | 109.70% 10-K · filed 2017-11-21 | 107.70% 10-K · filed 2015-11-24 |
| 2014-09-30 | 18.40% 10-K · filed 2016-11-22 | |
| 2013-09-30 | 2.30% 10-K · filed 2015-11-24 | |
| 2012-09-30 | 0.00% 10-K · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |